胸外科医师学会/美国放射肿瘤学会局部晚期食管或胃食管交界癌多学科治疗临床实践指南更新
该指南由胸外科医师学会(STS)、美国放射肿瘤学会(ASTRO)和美国临床肿瘤学会(ASCO)合作制定,针对局部晚期可切除胸段食管癌(除外颈段)提出8个关键临床问题,通过系统文献综述纳入227篇文章,经专家组投票(80%作者参与,类别和证据等级需75%同意)形成推荐,涵盖诱导化疗、化疗与放化疗对比、放疗剂量、食管切除术价值、手术时机、淋巴结清扫范围、微创食管切除术及术后辅助治疗。
要点
- 指南由STS、ASTRO和ASCO联合制定,针对局部晚期可切除胸段食管癌(除外颈段)的多学科治疗。
- 基于8个关键临床问题系统检索并纳入227篇文章,专家投票要求类别和证据等级75%同意。
- 推荐内容涉及诱导化疗、化疗对比放化疗、放疗剂量、食管切除术价值、手术时机、淋巴结清扫、微创手术及辅助治疗。
核心结论
- 该指南为局部晚期可切除胸段食管癌(除外颈段)的多学科治疗提供基于证据的推荐,涵盖诱导化疗、化疗与放化疗对比、放疗剂量、食管切除术价值、手术时机、淋巴结清扫范围、微创食管切除术及术后辅助治疗。
研究设计与样本
- 由胸外科医师学会(STS)、美国放射肿瘤学会(ASTRO)和美国临床肿瘤学会(ASCO)合作制定,医师代表选定8个关键临床问题,系统文献综述纳入227篇符合标准的文章,专家组投票要求80%作者参与且类别和证据等级75%同意。
主要发现
- 文献综述纳入227篇文章,覆盖诱导化疗、化疗对比放化疗、最佳放疗剂量、食管切除术价值、手术时机、淋巴结清扫方式与范围、微创食管切除术及术后辅助治疗的价值。
关键数值与推荐
- 专家投票要求80%的作者参与,且类别和证据等级需达到75%同意。
临床怎么用
- 原文未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Outcomes for patients with esophageal cancer have improved over the last decade with the implementation of multimodality therapy. There are currently no comprehensive guidelines addressing multidisciplinary management of esophageal cancer that have incorporated the input of surgeons, radiation oncologists, and medical oncologists. To address the need for multidisciplinary input in the management of esophageal cancer and to meet current best practices for clinical practice guidelines, the current guidelines were created as a collaboration between The Society of Thoracic Surgeons (STS), American Society for Radiation Oncology (ASTRO), and the American Society of Clinical Oncology (ASCO). Physician representatives chose 8 key clinical questions pertinent to the care of patients with locally advanced, resectable thoracic esophageal cancer (excluding cervical location). A comprehensive literature review was performed identifying 227 articles that met the inclusion criteria covering the use of induction chemotherapy, chemotherapy vs chemoradiotherapy before surgery, optimal radiation dose, the value of esophagectomy, timing of esophagectomy, the approach and extent of lymphadenectomy, the use of minimally invasive esophagectomy, and the value of adjuvant therapy after resection. The relevant data were reviewed and voted on by the panel with 80% of the authors, with 75% agreement on class and level of evidence. These data were then complied into the guidelines document.
引用
- Worrell SG, Goodman KA, Altorki NK, et al. The Society of Thoracic Surgeons/American Society for Radiation Oncology Updated Clinical Practice Guidelines on Multimodality Therapy for Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction. Ann Thorac Surg. 2023. PMID: 37921794. doi:10.1016/j.athoracsur.2023.09.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。